Department of Internal Medicine, SEICHE Center for Health and Justice, Yale School of Medicine, New Haven, Connecticut, USA.
Department of Internal Medicine, Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale School of Medicine, New Haven, Connecticut, USA.
Cancer Med. 2023 Jul;12(14):15447-15454. doi: 10.1002/cam4.6162. Epub 2023 May 29.
Cancer incidence among individuals with incarceration exposure has been rarely studied due to the absence of linked datasets. This study examined cancer incidence during incarceration and postincarceration compared to the general population using a statewide linked cohort.
We constructed a retrospective cohort from a linkage of state tumor registry and correctional system data for Connecticut residents from 2005 to 2016, and identified cancers diagnosed during and within 12 months postincarceration. We estimated incidence rates (including for screen-detectable cancers) and calculated the standardized incidence ratios (SIR) for the incarcerated and recently released populations, relative to the general population. We also examined cancer incidence by race and ethnicity within each group.
Cancer incidence was lower in incarcerated individuals (SIR = 0.64, 95% CI 0.56-0.72), but higher in recently released individuals (SIR = 1.34, 95% CI 1.23-1.47) compared with the general population, and across all race and ethnic strata. Similarly, nonscreen-detectable cancer incidence was lower in incarcerated and higher in recently released populations compared to the general population. However, non-Hispanic Black individuals had elevated incidence of screen-detectable cancers compared with non-Hispanic White individuals across all three populations (incarcerated, SIR = 1.66, 95% CI 1.03-2.53; recently released, SIR = 1.83, 95% CI 1.32-2.47; and general population, SIR = 1.18, 95% CI 1.16-1.21).
Compared with the general population, incarcerated persons have a lower cancer incidence, whereas recently released persons have a higher cancer incidence. Irrespective of incarceration status, non-Hispanic Black individuals have a higher incidence of screen-detectable cancers compared with non-Hispanic White individuals. Supplemental studies examining cancer screening and diagnoses during incarceration are needed to discern the reasons for observed disparities in incidence.
由于缺乏关联数据集,很少有研究关注监禁经历个体的癌症发病率。本研究利用全州范围的关联队列,比较了监禁期间和监禁后个体的癌症发病率与普通人群。
我们从 2005 年至 2016 年康涅狄格州居民的州肿瘤登记处和惩教系统数据的链接中构建了一个回顾性队列,并确定了在监禁期间和监禁后 12 个月内诊断出的癌症。我们估计了监禁人群和最近释放人群的发病率(包括可筛查癌症),并计算了相对于普通人群的标准化发病率比(SIR)。我们还在每个群体内按种族和族裔检查了癌症发病率。
与普通人群相比,监禁人群的癌症发病率较低(SIR=0.64,95%CI 0.56-0.72),而最近释放人群的癌症发病率较高(SIR=1.34,95%CI 1.23-1.47),且所有种族和族裔群体均如此。同样,与普通人群相比,监禁人群和最近释放人群的不可筛查癌症发病率较低。然而,在所有三个群体中,非西班牙裔黑人个体的可筛查癌症发病率均高于非西班牙裔白人个体(监禁人群,SIR=1.66,95%CI 1.03-2.53;最近释放人群,SIR=1.83,95%CI 1.32-2.47;普通人群,SIR=1.18,95%CI 1.16-1.21)。
与普通人群相比,监禁个体的癌症发病率较低,而最近释放个体的癌症发病率较高。无论监禁状态如何,与非西班牙裔白人个体相比,非西班牙裔黑人个体的可筛查癌症发病率均较高。需要进行补充研究来检查监禁期间的癌症筛查和诊断,以确定观察到的发病率差异的原因。